SGMT: Sagimet Biosciences Inc - Series A
今日SGMT汇率已更改-1.92%。当日,交易品种以低点6.12和高点6.36进行交易。
关注Sagimet Biosciences Inc - Series A动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
SGMT新闻
- Sagimet: Positive Denifanstat Combination PK Data Could Lead To Untapped Market (SGMT)
- Sagimet reports positive Phase 1 results for MASH combination therapy
- Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
- Sagimet Biosciences executive chairman sells $290k in shares
- Citizens上调Sagimet Biosciences目标价至35美元
- Sagimet Biosciences stock price target raised to $35 by Citizens
- 丹尼凡斯塔特在中国的第三期痤疮临床试验中达到所有终点
- Denifanstat meets all endpoints in phase 3 acne trial in China
- This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - First Solar (NASDAQ:FSLR), Klaviyo (NYSE:KVYO)
- Sagimet Biosciences获Clear Street给予买入评级
- Sagimet Biosciences stock initiated with Buy rating at Clear Street
- All You Need to Know About Sagimet Biosciences Inc. (SGMT) Rating Upgrade to Strong Buy
- Denifanstat Advances: Sagimet Builds Momentum Toward 2026 Readouts (NASDAQ:SGMT)
- 丹尼凡司他在3期痤疮治疗试验中达到所有终点指标
- Denifanstat meets all endpoints in phase 3 acne treatment trial
- Here's Why Sagimet Biosciences Inc. (SGMT) is Poised for a Turnaround After Losing 15.8% in 4 Weeks
- Tracking Baker Brothers Portfolio – Q2 2025 Update
- Sagimet Biosciences Inc. (SGMT) Cantor Global Healthcare Conference 2025 Transcript
- Sagimet (SGMT): Strong Denifanstat Pipeline Progress, Funding Overhang Keeps Stock At Hold
- Sagimet Gains Momentum As FDA Eases Path For MASH Drug Development (NASDAQ:SGMT)
- Sagimet Biosciences appoints KPMG as new auditor, replaces Deloitte
- Sagimet Biosciences Inc. (SGMT) Upgraded to Buy: What Does It Mean for the Stock?
- After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Sagimet Biosciences Inc. (SGMT)
- Sagimet Biosciences enters $75 million at-the-market sales agreement with Leerink Partners
常见问题解答
SGMT股票今天的价格是多少?
Sagimet Biosciences Inc - Series A股票今天的定价为6.14。它在6.12 - 6.36范围内交易,昨天的收盘价为6.26,交易量达到1201。SGMT的实时价格图表显示了这些更新。
Sagimet Biosciences Inc - Series A股票是否支付股息?
Sagimet Biosciences Inc - Series A目前的价值为6.14。股息政策取决于公司,而投资者也会关注45.50%和USD。实时查看图表以跟踪SGMT走势。
如何购买SGMT股票?
您可以以6.14的当前价格购买Sagimet Biosciences Inc - Series A股票。订单通常设置在6.14或6.44附近,而1201和-2.54%显示市场活动。立即关注SGMT的实时图表更新。
如何投资SGMT股票?
投资Sagimet Biosciences Inc - Series A需要考虑年度范围1.73 - 11.41和当前价格6.14。许多人在以6.14或6.44下订单之前,会比较2.33%和。实时查看SGMT价格图表,了解每日变化。
Sagimet Biosciences Inc - Series A股票的最高价格是多少?
在过去一年中,Sagimet Biosciences Inc - Series A的最高价格是11.41。在1.73 - 11.41内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Sagimet Biosciences Inc - Series A的绩效。
Sagimet Biosciences Inc - Series A股票的最低价格是多少?
Sagimet Biosciences Inc - Series A(SGMT)的最低价格为1.73。将其与当前的6.14和1.73 - 11.41进行比较,可以发现潜在的长期切入点。观看SGMT在图表上的实时走势以获取更多详细信息。
SGMT股票是什么时候拆分的?
Sagimet Biosciences Inc - Series A历史上曾经历过股票拆分。这些变化在公司行动后的、6.26和45.50%中可见。
- 前一天收盘价
- 6.26
- 开盘价
- 6.30
- 卖价
- 6.14
- 买价
- 6.44
- 最低价
- 6.12
- 最高价
- 6.36
- 交易量
- 1.201 K
- 日变化
- -1.92%
- 月变化
- 2.33%
- 6个月变化
- -28.60%
- 年变化
- 45.50%
- 实际值
- 预测值
- 前值